Table 1.
Baseline clinical characteristics of the study participants.
| Parameters | Group A (N = 25) |
Group B (N = 40) |
P value |
|---|---|---|---|
| Sex (M/F) | 19/6 | 28/12 | 0.599 |
| Age (years) | 53.76 ± 8.89 | 49.10 ± 10.57 | 0.071 |
| BMI (kg/m2) | 26.46 ± 4.60 | 24.63 ± 3.71 | 0.083 |
| SBP (mmHg) | 125.00 ± 7.65 | 123.63 ± 9.00 | 0.529 |
| DBP (mmHg) | 74.24 ± 8.74 | 73.75 ± 6.13 | 0.808 |
| FBG (mmol/L) | 7.43 ± 1.01 | 5.06 ± 0.50 | <0.001 |
| TC (mmol/L) | 4.62 ± 0.66 | 4.49 ± 0.74 | 0.461 |
| HDL (mmol/L) | 1.25 ± 0.29 | 1.61 ± 0.29 | <0.001 |
| LDL (mmol/L) | 2.80 ± 0.53 | 2.45 ± 0.62 | 0.023 |
| TG (mmol/L) | 3.05 ± 0.86 | 0.92 ± 0.37 | <0.001 |
| HbA1c (%) | 6.88 ± 0.72 | 5.42 ± 0.33 | <0.001 |
Group A, type 2 diabetes mellitus patients with hypertriglyceridemia; group B, control subjects; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; HbA1c, glycosylated hemoglobin.